Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (3844)	2/18/1998 6:03:00 PM
From: Steve Fancy	Read Replies (1) \| Respond to of 6136

Well monthly data was OK. My information is vague. My broker got it from a conference call with Elise Wang, and I got it from him as he was going out the door. I'll check later tonight for the recorded call...may or may not be there. He said monthly data total was 45466, of that 16877 were new...growth was flat, but growth is typically flat in January (not sure if he meant PI's, new drugs or what)...PI's as a class were up 2.4% month to month. He claimed that Elise said that with certain adjustments they were up 2%. What an odd statement...there's not many numbers I can't change with certain adjustments. He did not mention market share but kind of sounds like it stagnated...dosen't sound right based on the weekly data I remember. She apparently reiterated a buy, but did not mention a price target so I assume it remains unchanged. sf